ENTITY

X4 Pharmaceuticals (XFOR US)

5
Analysis
Health CareUnited States
X4 Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company specializes in developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases including primary immunodeficiencies and cancer. X4's oral small molecule drug candidates antagonize the CXCR4 pathway which plays a central role in immune surveillance.
more
Company Event21 Mar 2025 19:00 • Upcoming
Add To Calendar
Company Event13 Nov 2024 21:00 • Latest
Company Event08 Aug 2024 20:30
Company Event27 Jun 2024 20:00
Company Event07 May 2024 20:30
x